Paper36364196
Progression of Antiviral Agents Targeting Viral Polymerases.
Peng S and 3 others. Molecules, 2022. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Progression of Antiviral Agents Targeting Viral Polymerases. Papers, record 36364196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36364196
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics2
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| DNA-Directed RNA Polymerases | Major topic |
Source PubMed
References149
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33712437 | Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment. | Gut | 2022 | https://conductscience.org/library/papers/33712437 | PubMed |
| 2 | 12719561 | A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation. | J Virol | 2003 | https://conductscience.org/library/papers/12719561 | PubMed |
| 3 | 32326119 | FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells. | Microorganisms | 2020 | https://conductscience.org/library/papers/32326119 | PubMed |
| 4 | 21180544 | Therapeutic implications of hepatitis C virus resistance to antiviral drugs. | Ther Adv Gastroenterol | 2009 | https://conductscience.org/library/papers/21180544 | PubMed |
| 5 | 22185586 | Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase. | J Med Chem | 2012 | https://conductscience.org/library/papers/22185586 | PubMed |
| 6 | 27084036 | Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure. | J Hepatol | 2016 | https://conductscience.org/library/papers/27084036 | PubMed |
| 7 | 33524090 | Antiviral drug discovery: preparing for the next pandemic. | Chem Soc Rev | 2021 | https://conductscience.org/library/papers/33524090 | PubMed |
| 8 | 33945951 | Structure and function of SARS-CoV-2 polymerase. | Curr Opin Virol | 2021 | https://conductscience.org/library/papers/33945951 | PubMed |
| 9 | 8794733 | Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase. | Biochemistry | 1996 | https://conductscience.org/library/papers/8794733 | PubMed |
| 10 | 3039890 | Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis. | Ann Intern Med | 1987 | https://conductscience.org/library/papers/3039890 | PubMed |
| 11 | 24623983 | Approaches to hepatitis C treatment and cure using NS5A inhibitors. | Infect Drug Resist | 2014 | https://conductscience.org/library/papers/24623983 | PubMed |
| 12 | 21507964 | Replication-coupled and host factor-mediated encapsidation of the influenza virus genome by viral nucleoprotein. | J Virol | 2011 | https://conductscience.org/library/papers/21507964 | PubMed |
| 13 | 23022351 | Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection. | Antiviral Res | 2012 | https://conductscience.org/library/papers/23022351 | PubMed |
| 14 | 32283108 | Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites. | Antiviral Res | 2020 | https://conductscience.org/library/papers/32283108 | PubMed |
| 15 | 32601157 | HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32601157 | PubMed |
| 16 | 34040117 | The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials. | Sci Rep | 2021 | https://conductscience.org/library/papers/34040117 | PubMed |
| 17 | 23737047 | Introduction: the structural basis of virus function. | Subcell Biochem | 2013 | https://conductscience.org/library/papers/23737047 | PubMed |
| 18 | 27992102 | Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding. | Chembiochem | 2017 | https://conductscience.org/library/papers/27992102 | PubMed |
| 19 | 23436652 | Structural and functional characterization of K339T substitution identified in the PB2 subunit cap-binding pocket of influenza A virus. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23436652 | PubMed |
| 20 | 29946345 | IMP/GTP balance modulates cytoophidium assembly and IMPDH activity. | Cell Div | 2018 | https://conductscience.org/library/papers/29946345 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42769543 | The kynurenine pathway in RNA virus infection: immunometabolic control of antiviral defense and viral persistence. | Front Immunol | 2026 | https://conductscience.org/library/papers/42769543 | PubMed |
| 42549298 | Assessing Renal Dysfunction Incidence Related to Intravenous Acyclovir Usage. | Sultan Qaboos Univ Med J | 2026 | https://conductscience.org/library/papers/42549298 | PubMed |
| 42406005 | Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough. | Ther Innov Regul Sci | 2026 | https://conductscience.org/library/papers/42406005 | PubMed |
| 40455163 | Targeting Key Stages of the Viral Entry and Life Cycle: A Comprehensive Overview of the Mechanisms of Antiviral Actions. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40455163 | PubMed |
| 40210872 | Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40210872 | PubMed |
| 40183963 | Unlocking the dual power of Charybdis natator shell: antiviral and larvicidal activities. | Bioresour Bioprocess | 2025 | https://conductscience.org/library/papers/40183963 | PubMed |
| 40082688 | Identification of potent multi-target antiviral natural compounds from the fungal metabolites against aspartyl viral polymerases. | Sci Rep | 2025 | https://conductscience.org/library/papers/40082688 | PubMed |
| 39860981 | Advances and Challenges in Antiviral Development for Respiratory Viruses. | Pathogens | 2024 | https://conductscience.org/library/papers/39860981 | PubMed |
| 39769063 | Coumarins and Hesperetin Inhibit Human Respiratory Syncytial Virus Infection. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769063 | PubMed |
| 39339151 | Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39339151 | PubMed |
| 39125602 | Distinct Characteristic Binding Modes of Benzofuran Core Inhibitors to Diverse Genotypes of Hepatitis C Virus NS5B Polymerase: A Molecular Simulation Study. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39125602 | PubMed |
| 39066290 | Naturally Derived Terpenoids Targeting the 3Dpol of Foot-and-Mouth Disease Virus: An Integrated In Silico and In Vitro Investigation. | Viruses | 2024 | https://conductscience.org/library/papers/39066290 | PubMed |
| 39021763 | Protection of animals against devastating RNA viruses using CRISPR-Cas13s. | Mol Ther Nucleic Acids | 2024 | https://conductscience.org/library/papers/39021763 | PubMed |
| 38794231 | Small Molecule Drugs Targeting Viral Polymerases. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38794231 | PubMed |
| 38731287 | Potential Inhibitors of Lumpy Skin Disease's Viral Protein (DNA Polymerase): A Combination of Bioinformatics Approaches. | Animals (Basel) | 2024 | https://conductscience.org/library/papers/38731287 | PubMed |
| 37546653 | Discovery of Hybrid Thiouracil-Coumarin Conjugates as Potential Novel Anti-SARS-CoV-2 Agents Targeting the Virus's Polymerase "RdRp" as a Confirmed Interacting Biomolecule. | ACS Omega | 2023 | https://conductscience.org/library/papers/37546653 | PubMed |
| 36851211 | A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/36851211 | PubMed |
| 36770734 | Current Landscape of Methods to Evaluate Antimicrobial Activity of Natural Extracts. | Molecules | 2023 | https://conductscience.org/library/papers/36770734 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HCP5 | 10866 | PubTator's text mining | https://conductscience.org/library/genes/10866 | NCBI Gene |
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IL17RB | 55540 | PubTator's text mining | https://conductscience.org/library/genes/55540 | NCBI Gene |
| NEU1 | 4758 | PubTator's text mining | https://conductscience.org/library/genes/4758 | NCBI Gene |
| POLD3 | 10714 | PubTator's text mining | https://conductscience.org/library/genes/10714 | NCBI Gene |
| RNASEL | 6041 | PubTator's text mining | https://conductscience.org/library/genes/6041 | NCBI Gene |
| SMR3A | 26952 | PubTator's text mining | https://conductscience.org/library/genes/26952 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36364196
GET https://conductscience.org/api/papers/v1/36364196/references?page=2